Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Vascular Pharmacology|May 14, 2005
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effectAdaani E Frost, D Langleben, R Oudiz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionNimai Patel, Syed N Hyder, Erinleigh Michaud, et al.
JHLT Open|July 18, 2025
Impact of disease location and laterality on hemodynamic response following pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertensionBryan O Pérez Martínez, Gabriella V Rubick, Avi Toiv, et al.
Pulmonary Circulation|June 30, 2022
Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysisAnand Reddy Maligireddy, Supriya Shore, A Sreenivas Kumar, et al.
Pulmonary Circulation|November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
Chest|February 5, 2021
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON StudySean Gaine, Olivier Sitbon, Richard N Channick, et al.
Annals of the American Thoracic Society|August 9, 2023
Sex, Racial, and Geographic Disparities in Pulmonary Embolism-related Mortality NationwideMohamed Zghouzi, Hunter Mwansa, Supriya Shore, et al.
European Journal of Heart Failure|July 5, 2024
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbiditiesVallerie V McLaughlin, Olivier Sitbon, Kelly M Chin, et al.
Pulmonary Circulation|March 27, 2024
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertensionHunter Gillies, Murali M Chakinala, Benjamin T Dake, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
Pageof 17